XOMA Royalty (XOMA) Return on Sales Growth (3y) (2014 - 2026)
XOMA Royalty (XOMA) Return on Sales Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 1.00 |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 1.00 |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 26.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.00 |
| Dec 31, 2025 | 8.00 |
| Jun 30, 2025 | 37.00 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | -168.00 |
| Sep 30, 2024 | 6.00 |
| Jun 30, 2024 | -3.00 |
| Mar 31, 2024 | 12.00 |
| Dec 31, 2023 | -16.00 |
| Sep 30, 2023 | -54.00 |
| Jun 30, 2023 | 56.00 |
| Mar 31, 2023 | -16.00 |
| Dec 31, 2022 | 3.00 |
| Sep 30, 2022 | -33.00 |
| Jun 30, 2022 | -35.00 |
| Mar 31, 2022 | -1.00 |
| Dec 31, 2021 | 151.00 |
| Sep 30, 2021 | -3.00 |
| Jun 30, 2021 | -2.00 |
| Mar 31, 2021 | -20.00 |